Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Human Monoclonal Antibody TQC2938 Targeting the IL-33/ST2 Axis in Healthy Chinese Adults
Xin Tian(Zhengzhou University), Mei Li(Soochow University), Lihong Qi(University of California, Davis), Long Zhang(Nanjing Agricultural University), Rujiao Liu(Fudan University Shanghai Cancer Center), Shuang Wang(Dalian Medical University), Jie Zhang(Jiangnan University), Angang Yang(Henan Medical University), Shiyu Sun(Guizhou Normal University), Wujun Xue(First Affiliated Hospital of Xi'an Jiaotong University), Changhua Sun(First Affiliated Hospital of Zhengzhou University), Dongzhen Yu(Shanghai Jiao Tong University)
American Journal of Respiratory and Critical Care Medicine
May 1, 2025
Cited by 1
Related Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
|Nature Cancer|2021|279
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|JAMA Oncology|2020|245
Panax ginseng genome examination for ginsenoside biosynthesis
|GigaScience|2017|232